{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T21:05:39Z","timestamp":1790197539498,"version":"4.1.0"},"reference-count":79,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,8,16]],"date-time":"2024-08-16T00:00:00Z","timestamp":1723766400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,8,16]],"date-time":"2024-08-16T00:00:00Z","timestamp":1723766400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000090","name":"Congressionally Directed Medical Research Programs","doi-asserted-by":"publisher","award":["W81XWH-20-1-0276"],"award-info":[{"award-number":["W81XWH-20-1-0276"]}],"id":[{"id":"10.13039\/100000090","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000090","name":"Congressionally Directed Medical Research Programs","doi-asserted-by":"publisher","award":["W81XWH-20-1-0277"],"award-info":[{"award-number":["W81XWH-20-1-0277"]}],"id":[{"id":"10.13039\/100000090","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-69437-w","type":"journal-article","created":{"date-parts":[[2024,8,16]],"date-time":"2024-08-16T05:02:22Z","timestamp":1723784542000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Injectable, reversibly thermoresponsive captopril-laden hydrogel for the local treatment of sensory loss in diabetic neuropathy"],"prefix":"10.1038","volume":"14","author":[{"given":"Amit Chandra","family":"Das","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James M.","family":"Nichols","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caitlin V.","family":"Crelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riddhi","family":"Vichare","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hoang Vu","family":"Pham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caitlyn M.","family":"Gaffney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fisher R.","family":"Cherry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter M.","family":"Grace","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J.","family":"Shepherd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jelena M.","family":"Janjic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,8,16]]},"reference":[{"key":"69437_CR1","doi-asserted-by":"publisher","first-page":"1514","DOI":"10.1056\/NEJMoa1310799","volume":"370","author":"EW Gregg","year":"2014","unstructured":"Gregg, E. W. et al. Changes in diabetes-related complications in the United States, 1990\u20132010. N. Engl. J. Med. 370, 1514\u20131523 (2014).","journal-title":"N. Engl. J. Med."},{"key":"69437_CR2","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1016\/j.clinthera.2018.04.001","volume":"40","author":"Z Iqbal","year":"2018","unstructured":"Iqbal, Z. et al. Diabetic peripheral neuropathy: Epidemiology, diagnosis, and pharmacotherapy. Clin. Ther. 40, 828\u2013849 (2018).","journal-title":"Clin. Ther."},{"issue":"Suppl 1","key":"69437_CR3","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1002\/dmrr.2239","volume":"28","author":"S Tesfaye","year":"2012","unstructured":"Tesfaye, S. & Selvarajah, D. Advances in the epidemiology, pathogenesis and management of diabetic peripheral neuropathy. Diabetes Metab. Res. Rev. 28(Suppl 1), 8\u201314 (2012).","journal-title":"Diabetes Metab. Res. Rev."},{"key":"69437_CR4","doi-asserted-by":"crossref","unstructured":"Juster-Switlyk, K. & Smith, A.G. Updates in diabetic peripheral neuropathy. F1000Research 5, F1000 Faculty Rev-1738 (2016).","DOI":"10.12688\/f1000research.7898.1"},{"key":"69437_CR5","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1111\/ejn.13771","volume":"47","author":"VM Pham","year":"2018","unstructured":"Pham, V. M. et al. Impaired peripheral nerve regeneration in type-2 diabetic mouse model. Eur. J. Neurosci. 47, 126\u2013139 (2018).","journal-title":"Eur. J. Neurosci."},{"key":"69437_CR6","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1111\/j.1085-9489.2005.0010205.x","volume":"10","author":"JM Kennedy","year":"2005","unstructured":"Kennedy, J. M. & Zochodne, D. W. Impaired peripheral nerve regeneration in diabetes mellitus. J. Peripher. Nerv. Syst. 10, 144\u2013157 (2005).","journal-title":"J. Peripher. Nerv. Syst."},{"key":"69437_CR7","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.1097\/j.pain.0000000000000935","volume":"158","author":"J Vollert","year":"2017","unstructured":"Vollert, J. et al. Stratifying patients with peripheral neuropathic pain based on sensory profiles: Algorithm and sample size recommendations. Pain 158, 1446\u20131455 (2017).","journal-title":"Pain"},{"key":"69437_CR8","doi-asserted-by":"publisher","first-page":"108","DOI":"10.3132\/dvdr.2006.013","volume":"3","author":"TS Jensen","year":"2006","unstructured":"Jensen, T. S. et al. New perspectives on the management of diabetic peripheral neuropathic pain. Diab. Vasc. Dis. Res. 3, 108\u2013119 (2006).","journal-title":"Diab. Vasc. Dis. Res."},{"key":"69437_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3109\/07853890008995903","volume":"32","author":"RA Malik","year":"2000","unstructured":"Malik, R. A. Can diabetic neuropathy be prevented by angiotensin-converting enzyme inhibitors?. Ann. Med. 32, 1\u20135 (2000).","journal-title":"Ann. Med."},{"key":"69437_CR10","doi-asserted-by":"publisher","first-page":"R244","DOI":"10.1152\/ajpregu.00323.2011","volume":"302","author":"F Yiannikouris","year":"2012","unstructured":"Yiannikouris, F. et al. Adipocyte-specific deficiency of angiotensinogen decreases plasma angiotensinogen concentration and systolic blood pressure in mice. Am. J. Physiol. Regul. Integr. Comp. Physiol. 302, R244-251 (2012).","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"69437_CR11","doi-asserted-by":"publisher","first-page":"2271","DOI":"10.2337\/dc10-0349","volume":"33","author":"JK Yang","year":"2010","unstructured":"Yang, J. K. et al. Interactions among related genes of renin-angiotensin system associated with type 2 diabetes. Diabetes Care 33, 2271\u20132273 (2010).","journal-title":"Diabetes Care"},{"key":"69437_CR12","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.gene.2013.07.051","volume":"530","author":"A Inanir","year":"2013","unstructured":"Inanir, A., Basol, N., Karakus, N. & Yigit, S. The importance of association between angiotensin-converting enzyme (ACE) Gene I\/D polymorphism and diabetic peripheral neuropathy. Gene 530, 253\u2013256 (2013).","journal-title":"Gene"},{"key":"69437_CR13","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1097\/FBP.0000000000000025","volume":"25","author":"MT Smith","year":"2014","unstructured":"Smith, M. T., Lau, T., Wallace, V. C., Wyse, B. D. & Rice, A. S. Analgesic efficacy of small-molecule angiotensin II type 2 receptor antagonists in a rat model of antiretroviral toxic polyneuropathy. Behav. Pharmacol. 25, 137\u2013146 (2014).","journal-title":"Behav. Pharmacol."},{"key":"69437_CR14","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1016\/S0140-6736(13)62337-5","volume":"383","author":"ASC Rice","year":"2014","unstructured":"Rice, A. S. C. et al. EMA401, an orally administered highly selective angiotensin II type 2 receptor antagonist, as a novel treatment for postherpetic neuralgia: A randomised, double-blind, placebo-controlled phase 2 clinical trial. Lancet (London, England) 383, 1637\u20131647 (2014).","journal-title":"Lancet (London, England)"},{"key":"69437_CR15","doi-asserted-by":"publisher","first-page":"341","DOI":"10.2337\/diabetes.55.02.06.db05-0885","volume":"55","author":"LJ Coppey","year":"2006","unstructured":"Coppey, L. J. et al. ACE inhibitor or angiotensin II receptor antagonist attenuates diabetic neuropathy in streptozotocin-induced diabetic rats. Diabetes 55, 341\u2013348 (2006).","journal-title":"Diabetes"},{"key":"69437_CR16","doi-asserted-by":"publisher","first-page":"281","DOI":"10.36076\/ppj.2017.292","volume":"20","author":"CJ Roldan","year":"2017","unstructured":"Roldan, C. J., Song, J., Engle, M. P. & Dougherty, P. M. Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers modulate the function of myelinated fibers after chemotherapy: A quantitative sensory testing study. Pain Phys. 20, 281\u2013292 (2017).","journal-title":"Pain Phys."},{"key":"69437_CR17","doi-asserted-by":"publisher","first-page":"1978","DOI":"10.1016\/S0140-6736(98)02478-7","volume":"352","author":"RA Malik","year":"1998","unstructured":"Malik, R. A. et al. Effect of angiotensin-converting-enzyme (ACE) inhibitor trandolapril on human diabetic neuropathy: randomised double-blind controlled trial. Lancet (London, England) 352, 1978\u20131981 (1998).","journal-title":"Lancet (London, England)"},{"key":"69437_CR18","doi-asserted-by":"publisher","first-page":"6719239","DOI":"10.1155\/2017\/6719239","volume":"2017","author":"T Didangelos","year":"2017","unstructured":"Didangelos, T. et al. Efficacy of administration of an angiotensin converting enzyme inhibitor for two years on autonomic and peripheral neuropathy in patients with diabetes mellitus. J. Diabetes Res. 2017, 6719239 (2017).","journal-title":"J. Diabetes Res."},{"key":"69437_CR19","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1038\/sj.jhh.1002101","volume":"21","author":"P Dandona","year":"2007","unstructured":"Dandona, P., Dhindsa, S., Ghanim, H. & Chaudhuri, A. Angiotensin II and inflammation: The effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockade. J. Hum. Hypertens. 21, 20\u201327 (2007).","journal-title":"J. Hum. Hypertens."},{"key":"69437_CR20","doi-asserted-by":"publisher","DOI":"10.1097\/PR9.0000000000000869","author":"M Balogh","year":"2021","unstructured":"Balogh, M., Aguilar, C. A., Nguyen, N. T. & Shepherd, A. J. Angiotensin receptors and neuropathic pain. Pain Rep. https:\/\/doi.org\/10.1097\/PR9.0000000000000869 (2021).","journal-title":"Pain Rep."},{"key":"69437_CR21","doi-asserted-by":"publisher","first-page":"e84","DOI":"10.1213\/ANE.0000000000003857","volume":"128","author":"AJ Shepherd","year":"2019","unstructured":"Shepherd, A. J. & Mohapatra, D. P. Attenuation of unevoked mechanical and cold pain hypersensitivities associated with experimental neuropathy in mice by angiotensin II type-2 receptor antagonism. Anesth. Analgesia 128, e84\u2013e87 (2019).","journal-title":"Anesth. Analgesia"},{"key":"69437_CR22","doi-asserted-by":"publisher","first-page":"E8057","DOI":"10.1073\/pnas.1721815115","volume":"115","author":"AJ Shepherd","year":"2018","unstructured":"Shepherd, A. J. et al. Macrophage angiotensin II type 2 receptor triggers neuropathic pain. Proc. Natl. Acad. Sci. U. S. A. 115, E8057\u2013E8066 (2018).","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"69437_CR23","doi-asserted-by":"publisher","first-page":"7032","DOI":"10.1523\/JNEUROSCI.3542-17.2018","volume":"38","author":"AJ Shepherd","year":"2018","unstructured":"Shepherd, A. J. et al. Angiotensin II triggers peripheral macrophage-to-sensory neuron redox crosstalk to elicit pain. J. Neurosci. 38, 7032\u20137057 (2018).","journal-title":"J. Neurosci."},{"key":"69437_CR24","first-page":"14","volume":"6","author":"A Nehme","year":"2019","unstructured":"Nehme, A., Zouein, F. A., Zayeri, Z. D. & Zibara, K. An update on the tissue renin angiotensin system and its role in physiology and pathology. J. Cardiovasc. Dev. Dis. 6, 14 (2019).","journal-title":"J. Cardiovasc. Dev. Dis."},{"key":"69437_CR25","doi-asserted-by":"publisher","first-page":"10035","DOI":"10.1038\/srep10035","volume":"5","author":"A Nehme","year":"2015","unstructured":"Nehme, A. et al. Atlas of tissue renin-angiotensin-aldosterone system in human: A transcriptomic meta-analysis. Sci. Rep. 5, 10035 (2015).","journal-title":"Sci. Rep."},{"key":"69437_CR26","first-page":"Ra194","volume":"11","author":"ZJ Cheng","year":"2005","unstructured":"Cheng, Z. J., Vapaatalo, H. & Mervaala, E. Angiotensin II and vascular inflammation. Med. Sci. Monit. 11, Ra194-205 (2005).","journal-title":"Med. Sci. Monit."},{"key":"69437_CR27","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1161\/01.HYP.37.2.587","volume":"37","author":"U Kintscher","year":"2001","unstructured":"Kintscher, U. et al. Angiotensin II induces migration and Pyk2\/paxillin phosphorylation of human monocytes. Hypertension 37, 587\u2013593 (2001).","journal-title":"Hypertension"},{"key":"69437_CR28","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.freeradbiomed.2020.02.002","volume":"157","author":"L Piqueras","year":"2020","unstructured":"Piqueras, L. & Sanz, M. J. Angiotensin II and leukocyte trafficking: New insights for an old vascular mediator. Role of redox-signaling pathways. Free Radic. Biol. Med. 157, 38\u201354 (2020).","journal-title":"Free Radic. Biol. Med."},{"key":"69437_CR29","doi-asserted-by":"publisher","first-page":"e1111","DOI":"10.1212\/NXI.0000000000001111","volume":"9","author":"SS Gylfadottir","year":"2022","unstructured":"Gylfadottir, S. S. et al. Analysis of macrophages and peptidergic fibers in the skin of patients with painful diabetic polyneuropathy. Neurol. Neuroimmunol. Neuroinflamm. 9, e1111 (2022).","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"69437_CR30","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1097\/00004872-200203000-00024","volume":"20","author":"L Guasti","year":"2002","unstructured":"Guasti, L. et al. Changes in pain perception during treatment with angiotensin converting enzyme-inhibitors and angiotensin II type 1 receptor blockade. J. Hypertens. 20, 485\u2013491 (2002).","journal-title":"J. Hypertens."},{"key":"69437_CR31","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1161\/01.HYP.31.5.1146","volume":"31","author":"L Guasti","year":"1998","unstructured":"Guasti, L. et al. Treatment with enalapril modifies the pain perception pattern in hypertensive patients. Hypertension 31, 1146\u20131150 (1998).","journal-title":"Hypertension"},{"key":"69437_CR32","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1016\/S0149-2918(97)80086-0","volume":"19","author":"M Weber","year":"1997","unstructured":"Weber, M. Clinical safety and tolerability of losartan. Clin. Ther. 19, 604\u2013616 (1997).","journal-title":"Clin. Ther."},{"key":"69437_CR33","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1016\/S0140-6736(95)91988-0","volume":"345","author":"RM Herings","year":"1995","unstructured":"Herings, R. M., de Boer, A., Stricker, B. H., Leufkens, H. G. & Porsius, A. Hypoglycaemia associated with use of inhibitors of angiotensin converting enzyme. Lancet (London, England) 345, 1195\u20131198 (1995).","journal-title":"Lancet (London, England)"},{"key":"69437_CR34","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1080\/15685551.2018.1445416","volume":"21","author":"S Nawaz","year":"2018","unstructured":"Nawaz, S. et al. Biocompatible hydrogels for the controlled delivery of anti-hypertensive agent: Development, characterization and in vitro evaluation. Des. Monomers Polym. 21, 18\u201332 (2018).","journal-title":"Des. Monomers Polym."},{"key":"69437_CR35","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1080\/00914037.2020.1825080","volume":"71","author":"A Tayyab","year":"2020","unstructured":"Tayyab, A. et al. Formulation and optimization of captopril-loaded microspheres based compressed tablets: In vitro evaluation. Int. J. Polym. Mater. Polym. Biomater. 71, 233\u2013245 (2020).","journal-title":"Int. J. Polym. Mater. Polym. Biomater."},{"key":"69437_CR36","doi-asserted-by":"publisher","first-page":"2749","DOI":"10.1038\/s41467-019-10749-1","volume":"10","author":"SM Hashemnejad","year":"2019","unstructured":"Hashemnejad, S. M., Badruddoza, A. Z. M., Zarket, B., Ricardo Castaneda, C. & Doyle, P. S. Thermoresponsive nanoemulsion-based gel synthesized through a low-energy process. Nat. Commun. 10, 2749 (2019).","journal-title":"Nat. Commun."},{"key":"69437_CR37","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.ijpharm.2016.02.027","volume":"502","author":"K Al Khateb","year":"2016","unstructured":"Al Khateb, K. et al. In situ gelling systems based on Pluronic F127\/Pluronic F68 formulations for ocular drug delivery. Int. J. Pharm. 502, 70\u201379 (2016).","journal-title":"Int. J. Pharm."},{"key":"69437_CR38","doi-asserted-by":"publisher","first-page":"2372","DOI":"10.3390\/pharmaceutics15102372","volume":"15","author":"R Vichare","year":"2023","unstructured":"Vichare, R. et al. A reversibly thermoresponsive, theranostic nanoemulgel for tacrolimus delivery to activated macrophages: formulation and in vitro validation. Pharmaceutics 15, 2372 (2023).","journal-title":"Pharmaceutics"},{"key":"69437_CR39","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1016\/S0079-6700(03)00015-7","volume":"28","author":"G Riess","year":"2003","unstructured":"Riess, G. Micellization of block copolymers. Progress Polym. Sci. 28, 1107\u20131170 (2003).","journal-title":"Progress Polym. Sci."},{"key":"69437_CR40","doi-asserted-by":"publisher","first-page":"9694","DOI":"10.1021\/la401639g","volume":"29","author":"AM Pragatheeswaran","year":"2013","unstructured":"Pragatheeswaran, A. M. & Chen, S. B. Effect of chain length of PEO on the gelation and micellization of the pluronic F127 copolymer aqueous system. Langmuir 29, 9694\u20139701 (2013).","journal-title":"Langmuir"},{"key":"69437_CR41","doi-asserted-by":"publisher","first-page":"11658","DOI":"10.1038\/s41598-019-48254-6","volume":"9","author":"S Chatterjee","year":"2019","unstructured":"Chatterjee, S., Hui, P.C.-L., Kan, C.-W. & Wang, W. Dual-responsive (pH\/temperature) Pluronic F-127 hydrogel drug delivery system for textile-based transdermal therapy. Sci. Rep. 9, 11658 (2019).","journal-title":"Sci. Rep."},{"key":"69437_CR42","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.3390\/polym13081340","volume":"13","author":"M Pandey","year":"2021","unstructured":"Pandey, M. et al. Potential of stimuli-responsive in situ gel system for sustained ocular drug delivery: Recent progress and contemporary research. Polymers 13, 1340 (2021).","journal-title":"Polymers"},{"key":"69437_CR43","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1080\/15583724.2014.927885","volume":"54","author":"MSH Akash","year":"2014","unstructured":"Akash, M. S. H., Rehman, K. & Chen, S. Pluronic F127-based thermosensitive gels for delivery of therapeutic proteins and peptides. Polym. Rev. 54, 573\u2013597 (2014).","journal-title":"Polym. Rev."},{"key":"69437_CR44","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1007\/s13346-017-0381-8","volume":"7","author":"J Li","year":"2017","unstructured":"Li, J. et al. Enhancing thermal stability of a highly concentrated insulin formulation with Pluronic F-127 for long-term use in microfabricated implantable devices. Drug Deliv. Transl. Res. 7, 529\u2013543 (2017).","journal-title":"Drug Deliv. Transl. Res."},{"key":"69437_CR45","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.jcis.2019.12.096","volume":"565","author":"B Shriky","year":"2020","unstructured":"Shriky, B. et al. Pluronic F127 thermosensitive injectable smart hydrogels for controlled drug delivery system development. J. Colloid Interface Sci. 565, 119\u2013130 (2020).","journal-title":"J. Colloid Interface Sci."},{"key":"69437_CR46","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.1021\/acsmedchemlett.0c00198","volume":"11","author":"M Herneisey","year":"2020","unstructured":"Herneisey, M. et al. Design of thermoresponsive polyamine cross-linked perfluoropolyether hydrogels for imaging and delivery applications. ACS Med. Chem. Lett. 11, 2032\u20132040 (2020).","journal-title":"ACS Med. Chem. Lett."},{"key":"69437_CR47","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.jneuroim.2018.02.010","volume":"318","author":"JM Janjic","year":"2018","unstructured":"Janjic, J. M. et al. Low-dose NSAIDs reduce pain via macrophage targeted nanoemulsion delivery to neuroinflammation of the sciatic nerve in rat. J. Neuroimmunol. 318, 72\u201379 (2018).","journal-title":"J. Neuroimmunol."},{"key":"69437_CR48","doi-asserted-by":"crossref","unstructured":"Janjic, J.M. et al. In vitro Quality Assessments of Perfluorocarbon Nanoemulsions for Near-infrared Fluorescence Imaging of Inflammation in Preclinical Models. Bio-Protocol 13 (2023).","DOI":"10.21769\/BioProtoc.4842"},{"key":"69437_CR49","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1208\/s12249-018-1287-6","volume":"20","author":"M Herneisey","year":"2019","unstructured":"Herneisey, M. et al. Development of theranostic perfluorocarbon nanoemulsions as a model non-opioid pain nanomedicine using a quality by design (QbD) approach. AAPS PharmSciTech 20, 65 (2019).","journal-title":"AAPS PharmSciTech"},{"key":"69437_CR50","first-page":"85","volume":"42","author":"J Leanpolchareanchai","year":"2015","unstructured":"Leanpolchareanchai, J. Validation of analytical method for captopril extemporaneous preparations by high performance liquid chromatography. MU J. Pharm. Sci. 42, 85\u201392 (2015).","journal-title":"MU J. Pharm. Sci."},{"key":"69437_CR51","doi-asserted-by":"publisher","first-page":"249ra110","DOI":"10.1126\/scitranslmed.3008778","volume":"6","author":"T Gajanayake","year":"2014","unstructured":"Gajanayake, T. et al. A single localized dose of enzyme-responsive hydrogel improves long-term survival of a vascularized composite allograft. Sci. Transl. Med. 6, 249ra110 (2014).","journal-title":"Sci. Transl. Med."},{"key":"69437_CR52","doi-asserted-by":"publisher","first-page":"e0203409","DOI":"10.1371\/journal.pone.0203409","volume":"13","author":"D Dzhonova","year":"2018","unstructured":"Dzhonova, D. et al. Local release of tacrolimus from hydrogel-based drug delivery system is controlled by inflammatory enzymes in vivo and can be monitored non-invasively using in vivo imaging. PLoS One 13, e0203409 (2018).","journal-title":"PLoS One"},{"key":"69437_CR53","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1186\/s12974-021-02365-y","volume":"18","author":"JM Nichols","year":"2021","unstructured":"Nichols, J. M. et al. Tracking macrophages in diabetic neuropathy with two-color nanoemulsions for near-infrared fluorescent imaging and microscopy. J. Neuroinflamm. 18, 299 (2021).","journal-title":"J. Neuroinflamm."},{"key":"69437_CR54","doi-asserted-by":"publisher","first-page":"972309","DOI":"10.1117\/12.2213376","volume":"9723","author":"JM Janjic","year":"2016","unstructured":"Janjic, J. M. et al. NIR and MR imaging supported hydrogel based delivery system for anti-TNF alpha probiotic therapy of IBD. SPIE Proc. 9723, 972309 (2016).","journal-title":"SPIE Proc."},{"key":"69437_CR55","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/B978-0-323-89868-3.00023-9","volume-title":"Polymeric Micelles for Drug Delivery","author":"WH Abuwatfa","year":"2022","unstructured":"Abuwatfa, W. H., AlSawaftah, N. M. & Husseini, G. A. Chapter 21\u2014Block copolymer micelles as long-circulating drug delivery vehicles. In Polymeric Micelles for Drug Delivery (eds Kesharwani, P. & Greish, K.) 531\u2013560 (Woodhead Publishing, 2022)."},{"key":"69437_CR56","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1089\/biores.2014.0030","volume":"4","author":"L Liu","year":"2015","unstructured":"Liu, L., Bagia, C. & Janjic, J. M. The first scale-up production of theranostic nanoemulsions. Biores. Open Access 4, 218\u2013228 (2015).","journal-title":"Biores. Open Access"},{"key":"69437_CR57","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/s11892-016-0727-5","volume":"16","author":"R Pop-Busui","year":"2016","unstructured":"Pop-Busui, R., Ang, L., Holmes, C., Gallagher, K. & Feldman, E. L. Inflammation as a therapeutic target for diabetic neuropathies. Curr. Diab. Rep. 16, 29 (2016).","journal-title":"Curr. Diab. Rep."},{"key":"69437_CR58","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s12902-020-0511-z","volume":"20","author":"A Bidulescu","year":"2020","unstructured":"Bidulescu, A. et al. Associations of leptin and adiponectin with incident type 2 diabetes and interactions among African Americans: The Jackson heart study. BMC Endocrine Disorders 20, 31 (2020).","journal-title":"BMC Endocrine Disorders"},{"key":"69437_CR59","doi-asserted-by":"publisher","first-page":"386","DOI":"10.3389\/fimmu.2015.00386","volume":"6","author":"D R\u00f6hrborn","year":"2015","unstructured":"R\u00f6hrborn, D., Wronkowitz, N. & Eckel, J. DPP4 in diabetes. Front. Immunol. 6, 386 (2015).","journal-title":"Front. Immunol."},{"key":"69437_CR60","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1111\/j.1749-6632.2011.06320.x","volume":"1243","author":"R Ramasamy","year":"2011","unstructured":"Ramasamy, R., Yan, S. F. & Schmidt, A. M. Receptor for AGE (RAGE): signaling mechanisms in the pathogenesis of diabetes and its complications. Ann N Y Acad Sci 1243, 88\u2013102 (2011).","journal-title":"Ann N Y Acad Sci"},{"key":"69437_CR61","doi-asserted-by":"publisher","first-page":"35299","DOI":"10.1074\/jbc.273.52.35299","volume":"273","author":"I Shimomura","year":"1998","unstructured":"Shimomura, I., Shimano, H., Korn, B. S., Bashmakov, Y. & Horton, J. D. Nuclear sterol regulatory element-binding proteins activate genes responsible for the entire program of unsaturated fatty acid biosynthesis in transgenic mouse liver. J. Biol. Chem. 273, 35299\u201335306 (1998).","journal-title":"J. Biol. Chem."},{"key":"69437_CR62","doi-asserted-by":"publisher","first-page":"251","DOI":"10.7555\/JBR.34.20190124","volume":"34","author":"M Faraj","year":"2020","unstructured":"Faraj, M. LDL, LDL receptors, and PCSK9 as modulators of the risk for type 2 diabetes: A focus on white adipose tissue. J. Biomed. Res. 34, 251\u2013259 (2020).","journal-title":"J. Biomed. Res."},{"key":"69437_CR63","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1001\/archinte.163.1.93","volume":"163","author":"B Thorand","year":"2003","unstructured":"Thorand, B. et al. C-reactive protein as a predictor for incident diabetes mellitus among middle-aged men: Results from the MONICA Augsburg cohort study, 1984\u20131998. Arch. Intern. Med. 163, 93\u201399 (2003).","journal-title":"Arch. Intern. Med."},{"key":"69437_CR64","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.901616","author":"H Alfadul","year":"2022","unstructured":"Alfadul, H., Sabico, S. & Al-Daghri, N. M. The role of interleukin-1\u03b2 in type 2 diabetes mellitus: A systematic review and meta-analysis. Front. Endocrinol. https:\/\/doi.org\/10.3389\/fendo.2022.901616 (2022).","journal-title":"Front. Endocrinol."},{"key":"69437_CR65","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1161\/CIRCULATIONAHA.106.685230","volume":"115","author":"CM Matter","year":"2007","unstructured":"Matter, C. M. & Handschin, C. RANTES (regulated on activation, normal T cell expressed and secreted), inflammation, obesity, and the metabolic syndrome. Circulation 115, 946\u2013948 (2007).","journal-title":"Circulation"},{"key":"69437_CR66","doi-asserted-by":"publisher","first-page":"674","DOI":"10.18632\/aging.100064","volume":"1","author":"C Chavey","year":"2009","unstructured":"Chavey, C. & Fajas, L. CXCL5 drives obesity to diabetes, and further. Aging (Albany NY) 1, 674\u2013677 (2009).","journal-title":"Aging (Albany NY)"},{"key":"69437_CR67","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/j.bbagrm.2015.03.007","volume":"1849","author":"SJ Burke","year":"2015","unstructured":"Burke, S. J. et al. CCL20 is elevated during obesity and differentially regulated by NF-\u03baB subunits in pancreatic \u03b2-cells. Biochim. Biophys. Acta 1849, 637\u2013652 (2015).","journal-title":"Biochim. Biophys. Acta"},{"key":"69437_CR68","doi-asserted-by":"publisher","first-page":"638112","DOI":"10.3389\/fphys.2021.638112","volume":"12","author":"A Bhusal","year":"2021","unstructured":"Bhusal, A., Lee, W. H. & Suk, K. Lipocalin-2 in diabetic complications of the nervous system: Physiology, pathology, and beyond. Front. Physiol. 12, 638112 (2021).","journal-title":"Front. Physiol."},{"key":"69437_CR69","doi-asserted-by":"publisher","DOI":"10.1242\/bio.036830","author":"C De Gregorio","year":"2018","unstructured":"De Gregorio, C., Contador, D., Campero, M., Ezquer, M. & Ezquer, F. Characterization of diabetic neuropathy progression in a mouse model of type 2 diabetes mellitus. Biol. Open https:\/\/doi.org\/10.1242\/bio.036830 (2018).","journal-title":"Biol. Open"},{"key":"69437_CR70","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1038\/s41572-019-0092-1","volume":"5","author":"EL Feldman","year":"2019","unstructured":"Feldman, E. L. et al. Diabetic neuropathy. Nat. Rev. Dis. Primers 5, 42 (2019).","journal-title":"Nat. Rev. Dis. Primers"},{"key":"69437_CR71","first-page":"Cd007543","volume":"6","author":"BC Callaghan","year":"2012","unstructured":"Callaghan, B. C., Little, A. A., Feldman, E. L. & Hughes, R. A. Enhanced glucose control for preventing and treating diabetic neuropathy. Cochrane Database Syst. Rev. 6, Cd007543 (2012).","journal-title":"Cochrane Database Syst. Rev."},{"key":"69437_CR72","first-page":"193","volume":"15","author":"X Zhou","year":"2023","unstructured":"Zhou, X., Yu, G. & Yao, L. Efficacy of laser photocoagulation plus ranibizumab in patients with diabetic retinopathy and their effect on VEGF. Am. J. Transl. Res. 15, 193\u2013201 (2023).","journal-title":"Am. J. Transl. Res."},{"key":"69437_CR73","doi-asserted-by":"publisher","first-page":"2553","DOI":"10.1210\/jc.2012-4288","volume":"98","author":"SA Lee","year":"2013","unstructured":"Lee, S. A. et al. CD26\/DPP4 levels in peripheral blood and T cells in patients with type 2 diabetes mellitus. J. Clin. Endocrinol. Metab. 98, 2553\u20132561 (2013).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"69437_CR74","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1038\/35053000","volume":"409","author":"CM Steppan","year":"2001","unstructured":"Steppan, C. M. et al. The hormone resistin links obesity to diabetes. Nature 409, 307\u2013312 (2001).","journal-title":"Nature"},{"key":"69437_CR75","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1038\/aps.2018.40","volume":"39","author":"N Katsiki","year":"2018","unstructured":"Katsiki, N., Mikhailidis, D. P. & Banach, M. Leptin, cardiovascular diseases and type 2 diabetes mellitus. Acta Pharmacol. Sin. 39, 1176\u20131188 (2018).","journal-title":"Acta Pharmacol. Sin."},{"key":"69437_CR76","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.2337\/diacare.26.5.1540","volume":"26","author":"L Duvillard","year":"2003","unstructured":"Duvillard, L. et al. Cell surface expression of LDL receptor is decreased in type 2 diabetic patients and is normalized by insulin therapy. Diabetes Care 26, 1540\u20131544 (2003).","journal-title":"Diabetes Care"},{"key":"69437_CR77","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1021\/acs.accounts.0c00864","volume":"54","author":"M Chang","year":"2021","unstructured":"Chang, M. & Nguyen, T. T. Strategy for treatment of infected diabetic foot ulcers. Acc. Chem. Res. 54, 1080\u20131093 (2021).","journal-title":"Acc. Chem. Res."},{"key":"69437_CR78","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1093\/ndt\/15.9.1379","volume":"15","author":"T Nakamura","year":"2000","unstructured":"Nakamura, T. et al. Urinary excretion of podocytes in patients with diabetic nephropathy. Nephrol. Dial. Transplant. 15, 1379\u20131383 (2000).","journal-title":"Nephrol. Dial. Transplant."},{"key":"69437_CR79","doi-asserted-by":"publisher","first-page":"154434","DOI":"10.1016\/j.phymed.2022.154434","volume":"107","author":"J Yang","year":"2022","unstructured":"Yang, J. et al. Magnolol effectively ameliorates diabetic peripheral neuropathy in mice. Phytomedicine 107, 154434 (2022).","journal-title":"Phytomedicine"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-69437-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-69437-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-69437-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,16]],"date-time":"2024-08-16T06:06:48Z","timestamp":1723788408000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-69437-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,16]]},"references-count":79,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["69437"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-69437-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,16]]},"assertion":[{"value":"27 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"18978"}}